G Ahmed, HG Nasir, K Hall, L Weissmann - Cureus, 2020 - ncbi.nlm.nih.gov
Introduction: Khorana score (KS) stratifies patients into low, intermediate, and high risk groups for venous thromboembolism (VTE). We examined the generalizability of the KS to …
N van Es, M Ventresca, M Di Nisio… - … of Thrombosis and …, 2020 - Wiley Online Library
Background Oncology guidelines suggest using the Khorana score to select ambulatory cancer patients receiving chemotherapy for primary venous thromboembolism (VTE) …
A Parker, E Peterson, AYY Lee, C de Wit… - Journal of Thrombosis …, 2018 - Elsevier
Essentials• The Khorana score is validated for risk of venous thromboembolism (VTE) in cancer outpatients.• We conducted a multicenter analysis of medically hospitalized cancer …
Background: Guidelines suggest the use of the Khorana score to select patients with solid cancer receiving chemotherapy for thromboprophylaxis to prevent venous thromboembolism …
FI Mulder, M Candeloro, PW Kamphuisen… - …, 2019 - ncbi.nlm.nih.gov
We aimed to evaluate the performance of the Khorana score in predicting venous thromboembolic events in ambulatory cancer patients. Embase and MEDLINE were …
Introduction: Although venous thromboembolism (VTE) is a well-known complication of cancer, predicting and mitigating the risks associated with VTE related to cancer remain a …
The Khorana score is recommended for guiding primary venous thromboembolism (VTE) prophylaxis in cancer patients, but its clinical utility overall and across cancer types remains …
K Austin, J George, EJ Robinson, M Scully… - Journal of …, 2019 - ncbi.nlm.nih.gov
Background Guidelines do not recommend that cancer outpatients receive thromboprophylaxis unless at high venous thromboembolism (VTE) risk, with the Khorana …
S Chen, W Sun, M Dan, Y Sun, Y Jiang - Journal of Thrombosis and …, 2023 - Springer
Cancer patients with venous thromboembolism (VTE) are prone to poor prognoses. Thus, we aimed to develop a nomogram to predict the risk of VTE in these patients. We …